What is the basic mechanism of acidosis in acute kidney injury?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Basic Mechanism of Acidosis in Acute Kidney Injury

Acidosis in AKI develops primarily through impaired renal hydrogen ion excretion and reduced ammonia synthesis, leading to accumulation of nonvolatile acids in the body. 1

Primary Pathophysiologic Mechanisms

Impaired Acid Excretion

  • The kidneys normally excrete 50-100 mEq of hydrogen ions daily through tubular secretion and ammonia generation; AKI disrupts both processes, causing acid retention. 1
  • Damaged tubular epithelium loses the ability to secrete hydrogen ions into the tubular lumen, preventing normal acid elimination. 1
  • Reduced ammonia (NH₃) synthesis in the proximal tubule eliminates a critical buffer system—normally, ammonia combines with hydrogen ions to form ammonium (NH₄⁺), which is then excreted in urine. 1

Accumulation of Organic Acids

  • Decreased glomerular filtration prevents clearance of organic acids including sulfates, phosphates, and other uremic toxins, which accumulate and consume bicarbonate buffer. 2, 3
  • The anion gap typically increases as unmeasured anions (uremic acids) accumulate, though hyperchloremic (normal anion gap) acidosis can also occur depending on the clinical context. 3

Bicarbonate Loss and Regeneration Failure

  • The kidneys normally regenerate bicarbonate through proximal tubular reabsorption and distal tubular hydrogen ion secretion; AKI impairs both mechanisms. 1
  • Serum bicarbonate falls below 22 mmol/L as acid accumulates faster than the damaged kidneys can compensate, with severe AKI often producing bicarbonate levels below 18 mmol/L. 1, 4

Contributing Factors in Critical Illness

Tissue Hypoperfusion and Lactic Acidosis

  • Many AKI patients have concurrent shock states that generate lactic acidosis from inadequate oxygen delivery to tissues, compounding the uremic acidosis. 5
  • Septic shock produces a complex metabolic acidosis with contributions from lactate, hyperchloremia, and increased strong ion gap. 5

Impaired Respiratory Compensation

  • Severe illness may limit the respiratory system's ability to compensate by hyperventilating to eliminate CO₂, allowing pH to fall further. 5
  • Respiratory compensation (lowering PaCO₂) can partially offset metabolic acidosis, but this mechanism may be inadequate in critically ill patients with respiratory compromise. 5

Clinical Manifestations

Metabolic Derangements

  • Metabolic acidosis in AKI is characterized by pH <7.35, serum bicarbonate <22 mmol/L, and often an elevated anion gap (>12 mEq/L) from accumulated uremic toxins. 1, 5
  • Electrolyte disturbances including hyperkalemia, hypocalcemia, and hyperphosphatemia frequently accompany the acidosis. 2

Progression Pattern

  • The severity of acidosis correlates with AKI stage—stage 1 AKI may show mild bicarbonate reduction (18-22 mmol/L), while stage 3 AKI often produces severe acidosis with bicarbonate <15 mmol/L. 1, 4

Common Pitfalls

  • Do not assume all acidosis in AKI is purely uremic—always calculate the anion gap and measure lactate to identify concurrent lactic acidosis from hypoperfusion, which requires different management (fluid resuscitation and vasopressors rather than bicarbonate). 5, 3
  • Failing to recognize that bicarbonate therapy does not address the underlying renal dysfunction and should not delay renal replacement therapy when indicated. 2
  • Overlooking that rapid correction of severe acidosis with bicarbonate can precipitate life-threatening hypokalemia as alkalinization drives potassium intracellularly—monitor potassium every 2-4 hours during treatment. 4

References

Guideline

Acid-Base Disorders and Bicarbonate Levels

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Metabolic Acidosis Management in Chronic Kidney Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Acidosis in Shock: Pathophysiological Mechanisms and Clinical Implications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

How does Acute Kidney Injury (AKI) cause metabolic acidosis?
How do keto analogues work in managing Acute Kidney Injury (AKI)?
What are the acute indications for dialysis (Renal Replacement Therapy)?
Is it safe to give Tums (calcium carbonate) to a patient with Acute Kidney Injury (AKI)?
What is the association between Acute Kidney Injury (AKI) and metabolic acidosis?
What is the significance of a false‑positive anti‑Ku antibody result and how should it be evaluated and managed?
What are the differential diagnoses for a recurrent, painless, localized red eye that persists for about a month in the same quadrant?
In a non‑pregnant adult with a documented penicillin allergy, can ceftriaxone be used to treat syphilis and what are the recommended dosing regimens for early syphilis versus late latent or neurosyphilis?
How can I stage and explain in simple terms an echocardiogram that shows left ventricular ejection fraction 40‑45 % with global hypokinesis, grade I diastolic dysfunction, normal right ventricle and atria, trace mitral, tricuspid and aortic regurgitation, normal right‑ventricular systolic pressure, aortic atherosclerosis, and normal inferior vena cava collapse?
Is platelet‑rich plasma (PRP) appropriate for an adult with mild‑to‑moderate knee osteoarthritis (Kellgren‑Lawrence grade II‑III) after failure of weight control, exercise, NSAIDs, physical therapy, and intra‑articular corticosteroids or hyaluronic acid, and what protocol, expected benefits, risks, and contraindications should be considered?
What are the recommended dosing regimens, contraindications, and adverse effects of meclizine for motion‑induced nausea and vestibular vertigo?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.